参考文献

［1］Yahiya Y. Syed. Idarucizumab: A Review as a Reversal Agent for Dabigatran［J］. 2016, 16(4): 297-304.

［2］Finks Shannon W, Rogers Kelly C. Idarucizumab (Praxbind): The First Reversal Agent for a Direct Oral Anticoagulant［J］. 2017, 130(5): e195-e197.(https://www.daowen.com)

（郑　微　王　红）